Development outcome of the use of etamsylate for prevention of periventricular haemorrhage in a randomised controlled trial

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 90, Issue 1, 2005, Pages

  Schulte, J ^a   Osborne, J ^a   Benson, J W T ^b   Cooke, R ^c   Drayton, M ^f   Murphy, J ^d   Rennie, J ^e   Speidel, B D ^f  

^a ROYAL UNITED HOSPITAL   (United Kingdom)

^b Queen's Park Hospital   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^e Rosie Maternity Hospital   (United Kingdom)

^f SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETAMSYLATE; PLACEBO; HEMOSTATIC AGENT;

ARTICLE; AUDIOMETRY; BIRTH WEIGHT; BRAIN HEMORRHAGE; CEREBRAL PALSY; CHILD DEVELOPMENT; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROLOGIC EXAMINATION; NEWBORN; NEWBORN INTENSIVE CARE; PATENT DUCTUS ARTERIOSUS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; SURVIVAL; TREATMENT OUTCOME; UNITED KINGDOM; VERY LOW BIRTH WEIGHT; VISION; DRUG EFFECT; LOW BIRTH WEIGHT; PREMATURITY; RANDOMIZED CONTROLLED TRIAL;

CEREBRAL HEMORRHAGE; CEREBRAL PALSY; CHILD DEVELOPMENT; COGNITION DISORDERS; DOUBLE-BLIND METHOD; ETHAMSYLATE; FEMALE; FOLLOW-UP STUDIES; HEMOSTATICS; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; TREATMENT OUTCOME;

EID: 11144256193     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2003.035790     Document Type: Article

References (22)

1. Benson JWT, Drayton MR, Hayward C, et al. Multicentre trial of etamsylate for prevention of periventricular haemorrhage in very low birthweight infants. Lancet 1986;2:1297-300.
2. Papile L-A, Munsick-Bruno G, Shaefer A. Relationship of cerebral intraventricular haemorrhage and early childhood neurological handicap. J Pediatr 1983;103:273-7.
3. Steward AL, Thorburn RJ, Hope PL, et al. Ultrasound appearance of the brain in very preterm infants and neurodevelopmental outcome at 18 months of age. Arch Dis Child 1983;58:598-604.
4. McCarthy P. McCarthy scales of children's abilities. New York: Psychological Corporation, 1972.
5. Amiel-Tison C, Grenier A. Neurological assessment during the first year of life. New York: Oxford University Press, 1986.
6. Costello AMdeL, Hamilton PA, Baudin J, et al. Prediction of neurodevelopmental impairment at four years from brain ultrasound appearance of very preterm infants. Dev Med Child Neurol 1988;30:711-22.
7. Griffith HB, Jamjoom AB. The treatment of childhood hydrocephalus by choroid plexus coagulation and artificial cerebrospinal fluid. Br J Neurosurg 1990;4:95-100.
8. Altman DG. Practical statistics for medical research. Sections 10.3 and 9.6. London: Chapman and Hall, 1991.
9. Catto-Smith AG, Yu VYH, Bajuk B, et al. Effect of neonatal periventricular haemorrhage on neurodevelopmental outcome. Arch Dis Child 1985;60:8-11.
10. Palmer P, Dubowitz LMS, Levene MI, et al. Developmental and neurological progress of preterm infants with intraventricular haemorrhage and ventricular dilatation. Arch Dis Child 1982;57:748-53.
11. Graham M, Trounce JQm, Levene MI, et al. Prediction of cerebral palsy in very low birthweight infants: prospective ultrasound study. Lancet 1987;ii:593-6.
12. Steward AL, Reynolds EOR, Hope PL, et al. Probability of neurodevelopmental disorders estimated from ultrasound appearance of brains of very preterm infants. Dev Med Child Neurol 1987;29:3-11.
13. Levene MI. Cerebral ultrasound and neurological impairment: telling the future. Arch Dis Child 1990;65:469-71.
14. Mutch L, Johnson M, Morley R. Follow up studies: design organisation and analysis. Arch Dis Child 1989;64:1394-402.
15. Tin W, Fritz S, Wariyar U, et al. Outcome of very preterm birth: children reviewed with ease at 2 years differ from those followed up with difficulty. Arch Dis Child Fetal Neonatal Ed 1998;79:F83-7.
16. Elbourne D, Ayers S, Dellagrammaticas H, et al. Randomised controlled trial of prophylactic etamsylate: follow up at 2 years of age. Arch Dis Child Fetal Neonatal Ed 2001;84:F183-7.
17. Wigglesworth JS, Pape K. An integrated model for haemorrhagic and ischaemic lesions in the newborn brain. Early Hum Dev 1978;2/2:179-99.
18. Ment L, Duncan CC, Richmond MD, et al. Intraventricular haemorrhage in the preterm neonate: timing and cerebral blood flow changes. J Pediatr 1984;104:419-25.
19. Raichle M. The pathophysiology of brain ischaemia. Ann Neurol 1983;13:2-10.
20. Perlman JM, Hill A, Volpe JJ. The effect of patent ductus arteriosus on flow velocity in the anterior cerebral arteries: ductal steal in the premature newborn infant. J Pediatr 1981;99:767-71.
21. Chen JY. Etamsylate in the prevention of periventricular-intraventricular haemorrhage in premature infants. J Formos Med Assoc 1993;92:889-93.
22. Songhvi KP, Merchant RH, Kulkarni. Efficacy of etamsylate in preventing periventricular-intraventricular haemorrhage in newborns <34 weeks gestation. Pediatr Res 1998:193 (abstract 1124).